4,6-Dimethyl-2-(methylsulfonyl)pyrimidine

  • 4,6-Dimethyl-2-(methylsulfonyl)pyrimidine 1
  • 4,6-Dimethyl-2-(methylsulfonyl)pyrimidine 2
Product Description

Advance Intermediates for Ambrisentan

Read more Show less

CHEMCO INNOVATIVE CHEMIE PRIVATE LIMITED

  • Country/Region:
    India
  • Founded:
    1976
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    35144-22-0
  • Details
    Pulmonary Hypertension 
  • Selling Points
    Ethical Sourcing; Green Product; International Approvals/Standards; Quality Service; Reputation; -
  • Model
    -
  • Supplied from
    India
  • Measured In
    kilogram
More specifications Fewer specifications
Sales Markets
Show more Show less

CHEMCO INNOVATIVE CHEMIE PRIVATE LIMITED

  • Country/Region:
    India
  • Founded:
    1976
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
View company profile

More Products from CHEMCO INNOVATIVE CHEMIE PRIVATE LIMITED (40)

show all 40 other products

CHEMCO INNOVATIVE CHEMIE PRIVATE LIMITED resources (5)

  • Upcoming GMP Unit for Advanced Intermediates

    News Upcoming GMP Unit for Advanced Intermediates

    Chemco is expanding its pharmaceutical manufacturing capabilities through an upcoming GMP unit dedicated to advanced and penultimate intermediates. The facility is being developed to support customer programs linked to APIs including Acalabrutinib, Ambrisentan, Apixaban, Apremilast, Canagliflozin, Chlorthalidone, Dapagliflozin, Sotagliflozin, Doxofylline, Empagliflozin, Etoricoxib, Famotidine, Ibrutinib, Mirabegron, Tazemetostat, Ticagrelor and Praziquantel.

    The new unit will support process development, technology transfer, scale-up and commercial manufacturing, with a focus on reliable execution, long-term supply and customer-specific intermediate programs.

    1 Sep 2026
  • Brochure

    Brochure Brochure

  • Keynote 2025/26

    Brochure Keynote 2025/26

    We are thrilled to share our Keynote 2025/26 address by Mr. Samir Mody, Director of Chemco Group. He highlights our journey of innovation, recent advancements i
  • Chemco 2026 Brochure

    Brochure Chemco 2026 Brochure

    Established in 1976, Chemco is an Indian manufacturer with deep expertise in nitration and specialty chemistry. We are now advancing into KSMs, advanced and penultimate pharmaceutical intermediates, supporting customers from development and technology transfer through scale-up and long-term commercial manufacturing.

    Upcoming GMP Unit - December 2026. 
  • Product List

    Whitepaper Product List

    Please find our product list here.